X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (23) 23
index medicus (15) 15
female (12) 12
p-glycoprotein (10) 10
animals (8) 8
apoptosis (8) 8
cancer (8) 8
multidrug-resistance-1 gene (8) 8
expression (7) 7
male (7) 7
middle aged (7) 7
multidrug resistance-1 (7) 7
oncology (7) 7
resistance-1 mdr-1 system (7) 7
an-152 (6) 6
drug resistance (6) 6
antineoplastic agents - pharmacology (5) 5
antineoplastic agents - therapeutic use (5) 5
atp-binding cassette, sub-family b, member 1 - genetics (5) 5
atp-binding cassette, sub-family b, member 1 - metabolism (5) 5
care and treatment (5) 5
cell line, tumor (5) 5
gonadotropin-releasing hormone - analogs & derivatives (5) 5
high-affinity binding (5) 5
mice (5) 5
multidrug resistance-1 gene (5) 5
adult (4) 4
aged (4) 4
antineoplastic agents - metabolism (4) 4
chemotherapy (4) 4
cytotoxic analog (4) 4
doxorubicin - analogs & derivatives (4) 4
endometrial neoplasms - metabolism (4) 4
gonadotropin-releasing hormone - pharmacology (4) 4
human endometrial (4) 4
obstetrics & gynecology (4) 4
ovarian neoplasms - metabolism (4) 4
research (4) 4
treatment outcome (4) 4
tumors (4) 4
breast neoplasms - metabolism (3) 3
cells (3) 3
colorectal cancer (3) 3
dose-response relationship, drug (3) 3
doxorubicin (3) 3
doxorubicin - pharmacology (3) 3
drug resistance in microorganisms (3) 3
endocrinology & metabolism (3) 3
endometrial neoplasms - drug therapy (3) 3
immunosuppressive agents - therapeutic use (3) 3
in-vitro (3) 3
mice, inbred c57bl (3) 3
multidrug resistance (3) 3
multidrug-resistance gene (3) 3
ovarian cancer (3) 3
ovarian neoplasms - drug therapy (3) 3
pharmacology & pharmacy (3) 3
retroviral vector (3) 3
retroviridae - genetics (3) 3
review (3) 3
targeted therapy (3) 3
adolescent (2) 2
antirheumatic agents - therapeutic use (2) 2
apoptosis - drug effects (2) 2
arthritis, rheumatoid - drug therapy (2) 2
arthritis, rheumatoid - metabolism (2) 2
atp binding cassette transporter, sub-family b (2) 2
beta-catenin (2) 2
biochemistry & molecular biology (2) 2
biotechnology & applied microbiology (2) 2
blood stem-cells (2) 2
bone marrow cells - metabolism (2) 2
bone-marrow cells (2) 2
breast neoplasms - drug therapy (2) 2
breast-cancer (2) 2
calcium channel blockers - therapeutic use (2) 2
carcinoma (2) 2
cell proliferation (2) 2
colorectal neoplasms - genetics (2) 2
combined modality therapy (2) 2
cytotoxicity (2) 2
disease-free survival (2) 2
doxorubicin - metabolism (2) 2
doxorubicin - therapeutic use (2) 2
drug resistance, multiple - genetics (2) 2
drug-resistance (2) 2
endocrine system (2) 2
endometrial cancer (2) 2
functional polymorphisms (2) 2
gastroenterology & hepatology (2) 2
genetic aspects (2) 2
genetic therapy - methods (2) 2
genetic vectors (2) 2
genotoxicity (2) 2
gonadotropin-releasing hormone (2) 2
gonadotropin-releasing hormone - metabolism (2) 2
gonadotropin-releasing hormone - therapeutic use (2) 2
green fluorescent protein (2) 2
green fluorescent proteins (2) 2
growth (2) 2
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, ISSN 0002-9378, 10/2004, Volume 191, Issue 4, pp. 1164 - 1172
Objective: Eighty percent of human ovarian and endometrial cancers express receptors for luteinizing hormone-releasing hormone (LHRH-R). These receptors can be... 
NUDE-MICE | ACTIVATION | AN-152 | ovarian cancer | DOXORUBICIN | apoptosis | HIGH-AFFINITY BINDING | LINES | P-GLYCOPROTEIN | OBSTETRICS & GYNECOLOGY | IN-VITRO | GROWTH | endometrial cancer | multidrug resistance-1 | EXPRESSION | CARCINOMA
Journal Article
Frontiers in Endocrinology, ISSN 1664-2392, 08/2017, Volume 8, p. 187
Journal Article
Gynecologic Oncology, ISSN 0090-8258, 2010, Volume 119, Issue 3, pp. 457 - 461
Abstract Objectives Receptors for luteinizing hormone-releasing hormone (LHRH) can be utilized for targeted chemotherapy of cytotoxic LHRH analogs. The... 
Hematology, Oncology and Palliative Medicine | Obstetrics and Gynecology | AESZ-108 | AN-152 | LHRH receptors | Doxorubicin | Targeted chemotherapy | APOPTOSIS | HUMAN BREAST CANCERS | GYNECOLOGICAL CANCERS | CYTOTOXIC ANALOGS | OVARIAN CANCERS | RESISTANCE-1 MDR-1 SYSTEM | HORMONE-RELEASING HORMONE | HUMAN ENDOMETRIAL | OBSTETRICS & GYNECOLOGY | THERAPY | ONCOLOGY | Doxorubicin - blood | Humans | Middle Aged | Endometrial Neoplasms - metabolism | Gonadotropin-Releasing Hormone - administration & dosage | Antibiotics, Antineoplastic - adverse effects | Hydrocortisone - metabolism | Receptors, LHRH - biosynthesis | Antibiotics, Antineoplastic - blood | Gonadotropin-Releasing Hormone - analogs & derivatives | Breast Neoplasms - metabolism | Dose-Response Relationship, Drug | Gonadotropin-Releasing Hormone - pharmacokinetics | Doxorubicin - analogs & derivatives | Female | Ovarian Neoplasms - metabolism | Antibiotics, Antineoplastic - pharmacokinetics | Gonadotropin-Releasing Hormone - agonists | Ovarian Neoplasms - drug therapy | Doxorubicin - administration & dosage | Gonadotropin-Releasing Hormone - adverse effects | Ovarian Neoplasms - blood | Breast Neoplasms - drug therapy | Gonadotropin-Releasing Hormone - blood | Doxorubicin - pharmacokinetics | Antibiotics, Antineoplastic - administration & dosage | Maximum Tolerated Dose | Breast Neoplasms - blood | Endometrial Neoplasms - drug therapy | Endometrial Neoplasms - blood | Doxorubicin - adverse effects | Pituitary Gland - drug effects | Women | Anthracyclines | Chemotherapy | Dosage and administration | Cancer | Tumors | Index Medicus
Journal Article
Neuroendocrinology, ISSN 0028-3835, 07/2009, Volume 90, Issue 1, pp. 15 - 18
The luteinizing hormone-releasing hormone (LHRH; also known as gonadotropin-releasing hormone) receptor can be utilized for targeted chemotherapy with... 
At the Cutting Edge | Luteinizing hormone-releasing hormone | Receptor-targeted therapy | Gonadotropin-releasing hormone | AN-152 | APOPTOSIS | HUMAN-BREAST-CANCER | RESISTANCE-1 MDR-1 SYSTEM | CELL LINES | NEUROSCIENCES | HUMAN ENDOMETRIAL | LHRH | ENDOCRINOLOGY & METABOLISM | OVARIAN | GROWTH-FACTOR | EXPRESSION | CYTOTOXIC ANALOG | Doxorubicin - therapeutic use | Apoptosis - drug effects | Receptors, LHRH - chemistry | Humans | Endometrial Neoplasms - metabolism | Gonadotropin-Releasing Hormone - pharmacology | Antineoplastic Agents - therapeutic use | Doxorubicin - chemistry | Gonadotropin-Releasing Hormone - analogs & derivatives | Breast Neoplasms - metabolism | Antineoplastic Agents - metabolism | Genital Neoplasms, Female - drug therapy | Gonadotropin-Releasing Hormone - chemistry | Doxorubicin - analogs & derivatives | Drug Design | Female | Antineoplastic Agents - pharmacology | Doxorubicin - metabolism | Gonadotropin-Releasing Hormone - therapeutic use | Ovarian Neoplasms - metabolism | Receptors, LHRH - metabolism | Ovarian Neoplasms - drug therapy | Clinical Trials as Topic | Antineoplastic Agents - chemistry | Breast Neoplasms - drug therapy | Genital Neoplasms, Female - metabolism | Gonadotropin-Releasing Hormone - metabolism | Endometrial Neoplasms - drug therapy | Doxorubicin - pharmacology | Index Medicus
Journal Article
Journal Article
Oncology Reports, ISSN 1021-335X, 09/2011, Volume 26, Issue 3, pp. 629 - 635
Journal Article
GEBURTSHILFE UND FRAUENHEILKUNDE, ISSN 0016-5751, 12/2007, Volume 67, Issue 12, pp. 1359 - 1363
Journal Article
LEUKEMIA, ISSN 0887-6924, 01/2002, Volume 16, Issue 1, pp. 106 - 111
In view of the recent report of a myeloproliferative syndrome in mice that had received an MDR-1-transduced haemopoietic graft, we have investigated the... 
TYROSINE KINASE-ACTIVITY | PROGENITOR CELLS | MDR-1 | BONE-MARROW CELLS | p-glycoprotein | SELF-RENEWAL | MEDIATED TRANSFER | CHEMOPROTECTIVE GENE-TRANSFER | HEMATOPOIETIC-CELLS | MULTIDRUG-RESISTANCE-1 GENE | myelodysplasia | ONCOLOGY | FDCP-mix | O-6-ALKYLGUANINE-DNA ALKYLTRANSFERASE | HEMATOLOGY | MACROPHAGE INFLAMMATORY PROTEIN-1-ALPHA
Journal Article
Journal Article